Sell it all now while it has value and buy crypto.
HGEN isn't going to lose its value. The CAR-T indication alone is worth more than HGEN's current market cap of $500 million. And the Covid indication is far from over. The ACTIV-5 trial now has a patient population of those with a CRP<150mg/L and under 85 on remdesivir. The LIVE-AIR trial had 222% efficacy with that exact patient population. The market always overreacts to bad news. The share price could hit $9 by tomorrow.